Related Experiment Videos
4,9-diazapyrenium dications induce apoptosis in human tumor cells
I Steiner-Biocić1, L Glavas-Obrovac, I Karner
1Department of Biochemistry, Faculty of Food Technology, University of Osijek, Croatia.
Abstract:
We investigated the antiproliferative effects of two planar 4,9-diazapyrenium hydrogenasulphates against human malignant MiaPaCa 2 (pancreatic carcinoma), Hep 2 (laryngeal carcinoma) and human normal fibroblasts (WI 38) cell lines. The tested compounds were very potent in inhibiting the growth of the treated cell lines. Treatment with molar concentrations of the substances (10(-4)-10(-7) M) caused growth inhibition by more than 50%. The morphological changes of treated cells were also observed. Cells became smaller, with condensed chromatin and fragmented nuclei, the characteristics of dying cells. The identification of DNA-fragmentation and the appearance of chromatin aggregation leads us to assume the tested substances induced apoptosis of the investigated tumor cell lines.
Insights
Two novel compounds, 4,9-diazapyrenium hydrogenasulphates, show potent antiproliferative effects against pancreatic and laryngeal cancer cell lines. These compounds induce apoptosis, characterized by DNA fragmentation and chromatin condensation, in tumor cells.
Area of Science:
- Medicinal Chemistry
- Cell Biology
- Oncology
Background:
- Cancer remains a significant global health challenge, necessitating the development of novel therapeutic agents.
- Investigating new chemical entities for their cytotoxic and apoptotic potential is crucial for advancing cancer treatment strategies.
Purpose of the Study:
- To evaluate the antiproliferative activity of two planar 4,9-diazapyrenium hydrogenasulphates.
- To assess the impact of these compounds on malignant MiaPaCa 2 and Hep 2 cell lines, as well as normal WI 38 fibroblasts.
- To elucidate the mechanism of cell death induced by these compounds.
Main Methods:
- Cell culture of MiaPaCa 2 (pancreatic carcinoma), Hep 2 (laryngeal carcinoma), and WI 38 (normal fibroblasts).
- Treatment with varying molar concentrations (10(-4) to 10(-7) M) of the 4,9-diazapyrenium hydrogenasulphates.
- Morphological analysis of treated cells, including observation of chromatin condensation and nuclear fragmentation.
- Identification of DNA fragmentation to confirm apoptotic pathways.
Main Results:
- The 4,9-diazapyrenium hydrogenasulphates exhibited potent inhibition of cancer cell growth, with over 50% inhibition at tested concentrations.
- Significant morphological changes indicative of cell death were observed in treated malignant cells.
- Evidence of DNA fragmentation and chromatin aggregation strongly suggests the induction of apoptosis.
Conclusions:
- The tested 4,9-diazapyrenium hydrogenasulphates possess significant antiproliferative and apoptosis-inducing properties against pancreatic and laryngeal cancer cell lines.
- These compounds represent potential candidates for further investigation as novel anticancer agents.
- The observed apoptosis induction warrants further mechanistic studies to fully understand their therapeutic potential.